Koers Tetra Bio-Pharma Inc. Toronto S.E.
Aandelen
TBP
CA88166Y1007
Farmaceutische producten
Omzet 2020 | - | Omzet 2021 | - | Marktkapitalisatie | 88,81 mln. 121 mln. 81,8 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -26 mln. -35,48 mln. -23,95 mln. | Nettowinst (verlies) 2021 | -52 mln. -70,96 mln. -47,9 mln. | EV/omzet 2020 | - |
Nettoliquiditeiten 2020 | 501K 683K 461K | Nettoliquiditeiten 2021 | 1,77 mln. 2,42 mln. 1,63 mln. | EV/omzet 2021 | - |
K/w-verhouding 2020 |
-1,86
x | K/w-verhouding 2021 |
-1,7
x | Werknemers | 33 |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 99,01% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Michael Olders
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Catherine Auld
BRD | Director/Board Member | - | 28-05-21 |
H. Norton
CHM | Chairman | 63 | 17-09-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,31% | 6,19 mld. | |
-16,99% | 4,48 mld. | |
+6,39% | 3,29 mld. | |
-13,10% | 3,12 mld. | |
-4,17% | 2,5 mld. | |
+45,47% | 1,94 mld. | |
-9,11% | 1,68 mld. | |
-2,09% | 1,64 mld. | |
-12,50% | 1,56 mld. |